First Tarantino NFT sold for $1m
Raffaele Redi •
ZLAB
ZLAB
Zai Lab Limited, a biopharmaceutical company, engages in discovering or licensing, developing, and commercializing proprietary therapeutics that address medical needs in the fields of oncology, and autoimmune and infectious disease therapies in the People's Republic of China. Its drug candidates include ZL-2306, a poly ADP ribose polymerase 1/2 inhibitor, which is in Phase III clinical trial for the treatment of ovarian, lung, and breast cancers; ZL-2401, an antibiotic that is in Phase III clinical trial to treat ABSSSI, CABP, and UTI; FPA144, a humanized monoclonal antibody, which is in Phase I/III clinical trial to treat gastric and gastroesophageal cancer; ETX2514, a novel ß-lactamase inhibitor that is in Phase II cUTI trial for the treatment of acinetobacter baumannii; and ZL-2301, which is in Phase III clinical trial to treat HCC. The company's drug candidates also comprise ZL-3101, a novel steroid-sparing topical product that is in Phase II clinical trial for the treatment of eczema and psoriasis; and ZL-2302 to treat non-small cell lung cancer. The company, through its subsidiary, Zai Lab (Shanghai) Co. Ltd., has a collaboration agreement with the NovoCure Limited to perform clinical studies, sell, and import tumor treating field products in the field of oncology. Zai Lab Limited was founded in 2013 and is headquartered in Shanghai, the People's Republic of China.
White Paper Declaration
White Paper Declaration
1BTC
Invest
20BTC
Profit
Leverage:
x20
The Power Of Leverage
Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in
ZLAB price history
| Date | Close | Change | Change(%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 21, 2022 | 50.31 | -1.42 | -2.75% | 51.73 | 52.54 | 49.98 |
| Jan 20, 2022 | 51.99 | -1.19 | -2.24% | 53.18 | 54.86 | 51.68 |
| Jan 19, 2022 | 51.76 | 0.21 | 0.41% | 51.55 | 52.08 | 50.21 |
| Jan 18, 2022 | 52.32 | 4.33 | 9.02% | 47.99 | 54.12 | 47.82 |
| Jan 14, 2022 | 49.46 | -1.34 | -2.64% | 50.80 | 51.60 | 47.81 |
| Jan 13, 2022 | 51.35 | -3.44 | -6.28% | 54.79 | 54.83 | 51.03 |
| Jan 12, 2022 | 56.03 | -2.48 | -4.24% | 58.51 | 59.57 | 55.48 |
| Jan 11, 2022 | 58.41 | -0.01 | -0.02% | 58.42 | 60.22 | 57.07 |
| Jan 10, 2022 | 58.33 | 4.35 | 8.06% | 53.98 | 58.51 | 52.96 |
| Jan 7, 2022 | 54.78 | 1.47 | 2.76% | 53.31 | 58.16 | 53.30 |
| Jan 6, 2022 | 53.84 | 0.03 | 0.06% | 53.81 | 55.54 | 52.78 |
| Jan 5, 2022 | 53.94 | -3.38 | -5.90% | 57.32 | 58.97 | 53.51 |
| Jan 4, 2022 | 59.34 | -3.47 | -5.52% | 62.81 | 62.82 | 57.47 |
| Jan 3, 2022 | 64.14 | 2.28 | 3.69% | 61.86 | 64.70 | 60.11 |
| Dec 31, 2021 | 62.57 | -4.10 | -6.15% | 66.67 | 67.30 | 62.21 |
| Dec 30, 2021 | 66.64 | 4.27 | 6.85% | 62.37 | 68.20 | 62.37 |
| Dec 29, 2021 | 62.86 | -1.43 | -2.22% | 64.29 | 64.42 | 61.76 |
| Dec 28, 2021 | 64.99 | 0.22 | 0.34% | 64.77 | 66.74 | 64.76 |
| Dec 27, 2021 | 65.63 | 0.11 | 0.17% | 65.52 | 66.23 | 62.49 |
| Dec 23, 2021 | 65.42 | -1.41 | -2.11% | 66.83 | 68.13 | 64.73 |